Covid-19: William Shakespeare Receives Second Dose Of UK Coronavirus Vaccine As The World Watches

An 81-year-old man named William Shakespeare has become the second person in the world to receive the coronavirus vaccine outside of a trial.

Health authorities in the UK began rolling out the first doses of a widely tested and independently reviewed Covid-19 vaccine on Tuesday, kicking off a global immunization program that is expected to gain momentum as more serums gain approval.

The first shot occurred early in the morning at one of a network of hospitals across the country, where the initial phase of the UK program will be implemented in what has been dubbed “V-Day.”

Public health officials are asking the public to be patient because only those who are most at risk from Covid-19 will be vaccinated in the early stages. Medical staff will contact individuals to set up appointments, and most will have to wait until next year before there is enough vaccine to expand the program.

“I think there is a good chance that we will look back … [Tuesday] as marking a decisive turning point in the battle against coronavirus, ”said Sir Simon Stevens, executive director of the National Health Service.

READ MORE:
* Covid-19: Donald Trump’s administration missed the opportunity to block more doses of the Pfizer vaccine
* Covid-19: UK prepares for ‘V-Day’, its first vaccines in the war against coronavirus
* UK prepares for a great vaccination scheme watched by the world
* Covid-19: The beginning of the end of the coronavirus pandemic

The first recipient was Grandmother Margaret Keenan, who will turn 91 next week. He received the injection at Coventry University Hospital at 6:31 am (local time).

Keenan says she felt “very privileged to be the first person to be vaccinated against Covid-19.”

“It’s the best anticipated birthday gift I could wish for because it means that I can finally look forward to spending time with my family and friends in the new year after being alone for most of the year,” she said.

Shakespeare, a local from Warwickshire, who became the second receiver, said he was a bit concerned about the possible side effects, but thought the chance that they were bad would probably be low.

The first 800,000 doses go to people over the age of 80 who are hospitalized or already scheduled outpatient appointments, along with nursing home workers. Others will have to wait their turn.

Among the older Britons scheduled to get vaccinated is Hari Shukla of Newcastle.

“When I got the phone call, I was very excited to have the opportunity to join and be involved in that,” he said. “So we are very, very happy, happy and excited as well.”

Buckingham Palace declined to comment on reports that the 94-year-old queen and her 99-year-old husband, Prince Philip, would be vaccinated as a public example of their safety.

“Our aim is to fully protect all members of the population, Your Majesty, of course, too,” Dr June Raine, executive director of the UK Medicines and Health Products Regulatory Agency, told the BBC.

Public health officials elsewhere are watching Britain’s rollout as they prepare for the unprecedented task of vaccinating billions of people to end a pandemic that has killed more than 1.5 million. While the UK has a well-developed infrastructure for the delivery of vaccines, it is geared towards delivering them to groups such as school-age children or pregnant women, not the entire population.

The UK is making progress on the project after British regulators granted an emergency authorization on December 2 for the vaccine produced by US pharmaceutical company Pfizer and Germany’s BioNTech.

Authorities in the United States and the European Union are also reviewing the vaccine, along with rival products developed by the American biotech company Moderna, and a collaboration between the University of Oxford and the pharmaceutical company AstraZeneca.

On Saturday, Russia began vaccinating thousands of doctors, teachers and others at dozens of centers in Moscow with its Sputnik V vaccine. That program looks different because Russia authorized the use of Sputnik V last summer after it was released. tested on only a few dozen people.

The first shipments of the Pfizer-BioNTech vaccine were delivered to a select group of UK hospitals on Sunday.

At one such facility, Croydon University Hospital, south London, staff members couldn’t even touch the vials, but were delighted to have them in the building.

“I’m very proud,” said Louise Coughlan, deputy chief pharmacist for Croydon Health Services NHS Trust.

The vaccine may not reach the UK soon enough, which has had more than 61,000 Covid-related deaths and more than 1.7 million cases.

The 800,000 doses are only a fraction of what is needed. The government is targeting more than 25 million people, or about 40 percent of the population, in the first phase of its vaccination program, which prioritizes those who are most at risk of contracting the disease.

After the 80+ and nursing home workers, the program will expand as supply increases, and the vaccine will be offered roughly by age group, starting with the oldest.

In England, the vaccine will be delivered to 50 hospitals in the first wave of the program, with more hospitals expected to offer it as rollout progresses. Northern Ireland, Scotland and Wales are making their own plans under the UK’s decentralized administration system.

Logistical problems are slowing down the distribution of the Pfizer vaccine because it must be stored at minus 70 degrees Celsius.

The immunization program will be a “marathon, not a sprint,” said Professor Stephen Powis, NHS England Medical Director.

Authorities are also targeting large-scale distribution points because each vaccine package contains 975 doses and they don’t want it to go to waste.

The UK has agreed to buy millions of doses from seven different producers. Governments around the world are making agreements with various developers to ensure they ensure delivery of products that are ultimately approved for widespread use.